Abstract
The in-vitro activity of ceftazidime was determined against 586 clinical isolates of anaerobic bacteria by an agar-dilution technique and compared with that of cefuroxime, moxalactam and cefoxitin. At 16 mg/l, only 60% of all isolates were inhibited by ceftazidime, compared to 79% by cefuroxime, 81% by moxalactam and 80% by cefoxitin. Ceftazidime was relatively inactive against Bacteroides fragilis group, Lactobacillus and Clostridium species other than Cl. perfringens. Peptococcus, Peptostreptococcus, Cl. perfringens, microaerophilic streptococci and Propionibacterium were readily inhibited. Moxalactam was the most active agent against Bact. fragilis group, while cefuroxime was the most active agent against Streptococcus and Lactobacillus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
